Xspray Pharma AB (publ) (STO:XSPRAY)

Xspray Pharma AB Statistics

Total Valuation

STO:XSPRAY has a market cap or net worth of SEK 1.14 billion. The enterprise value is 1.14 billion.

Market Cap	1.14B
Enterprise Value	1.14B

Important Dates

The last earnings date was Thursday, March 26, 2026.

Earnings Date	Mar 26, 2026
Ex-Dividend Date	n/a

Share Statistics

STO:XSPRAY has 41.74 million shares outstanding. The number of shares has increased by 16.04% in one year.

Current Share Class	41.74M
Shares Outstanding	41.74M
Shares Change (YoY)	+16.04%
Shares Change (QoQ)	+10.59%
Owned by Insiders (%)	3.36%
Owned by Institutions (%)	36.84%
Float	28.25M

Valuation Ratios

PE Ratio	n/a
Forward PE	2.27
PS Ratio	462.96
PB Ratio	1.89
P/TBV Ratio	1.89
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-6.63
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.44, with a Debt / Equity ratio of 0.25.

Current Ratio	8.44
Quick Ratio	7.27
Debt / Equity	0.25
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-9.44

Financial Efficiency

Return on equity (ROE) is -27.93% and return on invested capital (ROIC) is -13.22%.

Return on Equity (ROE)	-27.93%
Return on Assets (ROA)	-12.70%
Return on Invested Capital (ROIC)	-13.22%
Return on Capital Employed (ROCE)	-21.28%
Weighted Average Cost of Capital (WACC)	4.64%
Revenue Per Employee	94,846
Profits Per Employee	-6.59M
Employee Count	26
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	-104,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -9.08% in the last 52 weeks. The beta is -0.03, so STO:XSPRAY's price volatility has been lower than the market average.

Beta (5Y)	-0.03
52-Week Price Change	-9.08%
50-Day Moving Average	26.04
200-Day Moving Average	35.67
Relative Strength Index (RSI)	50.45
Average Volume (20 Days)	78,874

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, STO:XSPRAY had revenue of SEK 2.47 million and -171.44 million in losses. Loss per share was -4.46.

Revenue	2.47M
Gross Profit	2.47M
Operating Income	-159.13M
Pretax Income	-171.55M
Net Income	-171.44M
EBITDA	-156.54M
EBIT	-159.13M
Loss Per Share	-4.46

Balance Sheet

The company has 153.75 million in cash and 148.39 million in debt, with a net cash position of 5.35 million or 0.13 per share.

Cash & Cash Equivalents	153.75M
Total Debt	148.39M
Net Cash	5.35M
Net Cash Per Share	0.13
Equity (Book Value)	604.65M
Book Value Per Share	14.49
Working Capital	161.23M

Cash Flow

Operating Cash Flow	-193.16M
Capital Expenditures	n/a
Depreciation & Amortization	2.59M
Net Borrowing	14.86M
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	100.00%
Operating Margin	-6,453.12%
Pretax Margin	-6,956.49%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

STO:XSPRAY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.04%
Shareholder Yield	-16.04%
Earnings Yield	-15.02%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

STO:XSPRAY has an Altman Z-Score of 2.89 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.89
Piotroski F-Score	1